ORIGINAL ARTICLE |
|
Year : 2015 | Volume
: 1
| Issue : 3 | Page : 63-66 |
|
X syndrome prevalence among infertile women need reproductive technology In vitro fertilisation and intracytoplasmic sperm injection
Maryam Kianpour1, Mina Fazlollahi Mohammadi2, Ashraf Kazami1, Seyed Mehdi Ahmadi3
1 Department of Midwifery, Faculty of Nursing and Midwifery, Isfahan University of Medical Sciences, Isfahan, Iran 2 Department of Health Education and Health Promotion, School of Health, Isfahan University of Medical Sciences, Isfahan, Iran 3 Isfahan Fertility and Infertility Center, Isfahan, Iran
Correspondence Address:
Mina Fazlollahi Mohammadi Department of Health Education and Health Promotion, School of Health, Isfahan University of Medical Sciences, Isfahan Iran
Source of Support: None, Conflict of Interest: None | Check |
DOI: 10.4103/2468-6565.190978
|
|
Introduction: The different prevalence of metabolic syndrome in numerous populations justifies its determination in order to assist design strategies for screening programs to prevent long-term complications. Then, the current survey was aimed to determine the prevalence of metabolic syndrome in infertile women referring to an infertility clinic in Isfahan city.
Materials and Methods: Prevalence of metabolic syndrome was determined in a cross-sectional survey conducted on 149 women require reproductive techniques in infertility clinics in Isfahan. These samples were selected using convenient sampling through patients referring in the clinic during January 2013 to June 2014. Metabolic syndrome was diagnosed according to National Cholesterol Education Programme Adult Treatment Panel III criteria.
Results: The mean age of women was 32.2 ± 5.3 years. Prevalence of metabolic syndrome was 33.4% (49 women). With regards to the findings, the most frequent feature of metabolic syndrome was abdominal circumference by 70% (103 women) and the lowest one was about blood sugar by 18.2% (12 patients).
Conclusion: The current results revealed that the prevalence of metabolic syndrome in infertile women was 33.4%, then screening of infertile women in terms of indicators of syndrome before entering the costly process of reproductive technology recommended due to its adverse effect on fertility. |
|
|
|
[FULL TEXT] [PDF]* |
|
|
|